CVS Health Corporation $CVS Stock Sold by Pzena Investment Management LLC

Pzena Investment Management LLC trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 12.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,296,903 shares of the pharmacy operator’s stock after selling 1,472,633 shares during the period. CVS Health makes up about 2.6% of Pzena Investment Management LLC’s holdings, making the stock its 14th largest holding. Pzena Investment Management LLC owned about 0.81% of CVS Health worth $882,342,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC boosted its holdings in CVS Health by 41.8% in the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 105 shares during the period. HBW Advisory Services LLC grew its stake in CVS Health by 3.5% during the 3rd quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock worth $292,000 after purchasing an additional 115 shares in the last quarter. Apella Capital LLC increased its holdings in CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after purchasing an additional 117 shares during the period. Wellington Altus USA Inc. raised its position in CVS Health by 13.3% in the 2nd quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock valued at $106,000 after purchasing an additional 120 shares in the last quarter. Finally, Childress Capital Advisors LLC boosted its stake in shares of CVS Health by 3.9% in the 3rd quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock valued at $300,000 after buying an additional 131 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CVS shares. Cantor Fitzgerald reissued a “neutral” rating on shares of CVS Health in a research report on Friday, October 9th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research report on Thursday, August 6th. Truist Financial raised their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. JPMorgan Chase & Co. increased their target price on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Finally, Piper Sandler set a $112.00 price objective on CVS Health in a research report on Wednesday, September 9th. Twenty-two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $109.46.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS reported Q3 adjusted earnings of $2.09 per share, above the $1.65 consensus estimate, while revenue rose 5.4% year over year to $108.4 billion. Management raised its 2026 adjusted EPS outlook to at least $8.20 from a prior range of $7.90–$8.10. CVS Q3 results and guidance
• Neutral Sentiment: The company plans to separate its retail pharmacy business from its health benefits, pharmacy-benefit and care operations, creating two publicly traded companies by the first half of 2028. CVS says the businesses could gain focus and strategic flexibility, though the separation is still more than a year away. CVS breakup plan
• Negative Sentiment: The breakup announcement appears to be the main overhang: investors are reacting warily to CVS reversing its vertically integrated strategy, including the Aetna combination, despite the earnings beat. The scale and complexity of unwinding the businesses may be fueling uncertainty around execution and the value of the new structure. Market reaction to CVS split plan

CVS Health Stock Down 12.6%

CVS Health stock opened at $79.90 on Thursday. The company has a market capitalization of $102.19 billion, a P/E ratio of 21.14, a PEG ratio of 0.85 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The stock has a 50-day simple moving average of $90.82 and a 200-day simple moving average of $88.86.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The company had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. During the same quarter in the previous year, the company posted $1.60 earnings per share. The firm’s revenue was up 5.4% compared to the same quarter last year. Equities research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were issued a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s payout ratio is presently 70.37%.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.